Loading...
Current status of cancer immunotherapy
To prove clinical benefits of cancer vaccine is currently difficult, except for one phase III trial has documented improved overall survival with the vaccine, Sipuleucel-T, although induction of anti-tumor immune responses through cancer vaccine is theoretically promising and would be straightforwar...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Journal of Stem Cells and Regenerative Medicine
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4112273/ https://ncbi.nlm.nih.gov/pubmed/25075156 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|